XTL Biopharmaceuticals Ltd.
XTLB | NASDAQ
$2.25
-$0.13 (-5.46%)
Sep 22, 2026, 10:25 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -6.97M | -1.03M | -1.78M | -1.35M | 435K | -2.95M |
Depreciation & Amortization | n/a | 199K | n/a | 1K | 1K | 1K |
Stock-Based Compensation | 346K | 264K | 3K | 14K | 37K | 51K |
Other Working Capital | 28K | -58K | 45K | 25K | -31K | 23K |
Other Non-Cash Items | 5.6M | -1.11M | 1.01M | -36K | -1.47M | 2.01M |
Deferred Income Tax | n/a | -130K | n/a | 487K | n/a | n/a |
Change in Working Capital | -2K | 189K | 64K | -19K | -54K | 45K |
Operating Cash Flow | -1.03M | -1.62M | -707K | -901K | -1.05M | -850K |
Capital Expenditures | n/a | -54K | n/a | n/a | n/a | -1K |
Cash Acquisitions | -5K | -410K | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -14K | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 777K | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -250K | -366K | 41K | 36K | 8K | 33K |
Investing Cash Flow | 522K | -844K | 41K | 36K | 8K | 32K |
Debt Repayment | 208K | -13K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 208K | 1.45M | n/a | n/a | 385K | n/a |
Net Cash Flow | -295K | -1.03M | -693K | -875K | -662K | -824K |
Free Cash Flow | -1.03M | -1.67M | -707K | -901K | -1.05M | -851K |
Adj. Free Cash Flow | -1.37M | -1.94M | -710K | -915K | -1.09M | -902K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | -1K |
Growth CapEx | n/a | -54K | n/a | n/a | n/a | n/a |
Owner Earnings | -1.03M | -1.62M | -707K | -901K | -1.05M | -851K |
Add to Watchlist
Select watchlists to add or remove XTLB